Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Oxid Med Cell Longev ; 2019: 3829342, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31885785

RESUMO

Little information has been available about the influence of dietary genistein (GEN) on hepatic transcriptome of laying broiler breeder (LBB) hens. The study is aimed at broadening the understanding of RNA expression profiles and alternative splicing (AS) signatures of GEN-treated breeder hens and thereby improving laying performance and immune function of hens during the late egg-laying period. 720 LBB hens were randomly allocated into three groups with supplemental dietary GEN doses (0, 40 mg/kg, and 400 mg/kg). Each treatment has 8 replicates of 30 birds. Dietary GEN enhanced the antioxidative capability of livers, along with the increased activities of glutathione peroxidase and catalase. Furthermore, it improved lipid metabolic status and apoptotic process in the liver of hens. 40 mg/kg dietary GEN had the better effects on improving immune function and laying performance. However, transcriptome data indicated that 400 mg/kg dietary GEN did negative regulation of hormone biosynthetic process. Also, it upregulated the expressions of EDA2R and CYR61 by the Cis regulation of neighbouring genes (lncRNA_XLOC_018890 and XLOC_024242), which might activate NF-κB and immune-related signaling pathway. Furthermore, dietary GEN induced AS events in the liver, which also enriched into immune and metabolic process. Therefore, the application of 40 mg/kg GEN in the diet of breeder hens during the late egg-laying period can improve lipid metabolism and immune function. We need to pay attention to the side-effects of high-dose GEN on the immune function.


Assuntos
Processamento Alternativo/efeitos dos fármacos , Genisteína/farmacologia , Fígado/efeitos dos fármacos , RNA/metabolismo , Transcriptoma/efeitos dos fármacos , Animais , Antioxidantes/metabolismo , Galinhas , Proteína Rica em Cisteína 61/genética , Proteína Rica em Cisteína 61/metabolismo , Suplementos Nutricionais , Fígado/metabolismo , RNA Longo não Codificante/metabolismo , Triglicerídeos/sangue , Receptor Xedar/genética , Receptor Xedar/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA